Verus Capital Partners’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Verus Capital Partners’s Portfolio BTEC Stock Details BTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$17K	Buy	+544	New	+$19.9K	0.01%	855

Other funds holding BTEC

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Verus Capital Partners's BTEC Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q1 2020: 544 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #855 among its holdings.

9 funds tracked by Wall St. Rank hold BTEC as of Q1 2020.

Verus Capital Partners held 544 shares of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF worth $17K as of Q1 2020.
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF was a new Verus Capital Partners position in Q1 2020.
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #855 holding.
9 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.